Results 271 to 280 of about 3,067,002 (353)

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Acute kidney injury after lung transplantation: prediction, prevention, and management. [PDF]

Ren Fail
Ye C, Huang J, Ye T, Ke L, Jiang X, Zhu C.   +5 more
europepmc   +1 more source

Single lung transplantation

The Journal of Thoracic and Cardiovascular Surgery, 1984
openaire   +2 more sources

A contemporary simple risk score for prediction of severe acute kidney injury after heart transplantation

ESC Heart Failure, Volume 12, Issue 2, Page 1166-1175, April 2025.
A contemporary simple risk score for prediction of severe AKI after HT. Abstract Background The aim of this study was to develop a simple risk score to estimate severe acute kidney injury (AKI) risk based on a large contemporary heart transplantation (HT) cohort.
Shuangshuang Zhu, Weihua Qiao, Yixuan Wang, Ying Zhou, Yin Xu, Shijie Wang, Tian Xia, Guohua Wang, Si Chen, Jiawei Shi, Nianguo Dong   +10 more
wiley   +1 more source

A Potential Novel Molecular Interaction in Bronchiolitis Obliterans Syndrome in Lung Transplantation Patients: The Role of SERPINA3 and Osteoprotegerin. [PDF]

FASEB J
Liu Y, van der Ploeg EA, Borghuis T, Menz RI, Timens W, Vonk JM, Melgert BN, Gan CT, Burgess JK.   +8 more
europepmc   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Universal screening for hyperammonemia after lung transplantation: A retrospective cohort study of incidence and outcomes. [PDF]

JHLT Open
Wick KD, Patil J, Dunitz J, Billings J, Kiel S, Mahan K, Lambert C, Hertz M, Shumway S, Lee H, Huddleston S, Kumar A.   +11 more
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Current approaches to minimally invasive lung transplantation-a technical guide. [PDF]

JTCVS Tech
Catarino P, Chang SH, Emerson D, Megna DJ, Geraci TC, Grossi EA, Demarest CT, Stokes J, Hoetzenecker K.   +8 more
europepmc   +1 more source

Logistics and management of the multiple organ donor [PDF]

, 1994
Doyle, HR, Marino, IR, Scotti-Foglieni, C, Starzl, TE   +3 more
core